Sartorius Aktiengesellschaft (SRT3.F)
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide.
222.90+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+23.0%
The outlook
Sartorius Aktiengesellschaft currently reads as neutral based on buy — 1.9 avg of 19 analysts, below its 50- & 200-day averages, 52% of the way from its 52-week low to high, avg target +19% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.9 avg of 19 analysts
Price trendBelow its 50- & 200-day averages
52-week range52% of the way from its 52-week low to high
Price targetAvg target +19% vs current price
Analyst price target
~12-month · 19 analysts265.95average target+19.3% vs now
Now 222.90
Low 190.00High 307.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$15.39B
52-wk high
265.00
52-wk low
177.10
50-day avg
231.09
200-day avg
232.11
Trailing P/E
79.0